PDB Short entry for 2KLY HEADER LIGASE 10-JUL-09 2KLY TITLE SOLUTION STRUCTURE OF HUMAN UBIQUITIN CONJUGATING ENZYME UBE2G2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: UBIQUITIN-CONJUGATING ENZYME E2 G2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: UBIQUITIN-PROTEIN LIGASE G2, UBIQUITIN CARRIER PROTEIN G2; COMPND 5 EC: 6.3.2.19; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: UBE2G2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET28B KEYWDS ALPHA BETA FOLD, ATP-BINDING, LIGASE, NUCLEOTIDE-BINDING, UBL KEYWDS 2 CONJUGATION PATHWAY EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR T.JU,W.BOCIK,A.MAJUMDAR,J.R.TOLMAN REVDAT 2 16-MAR-22 2KLY 1 REMARK SEQADV REVDAT 1 02-MAR-10 2KLY 0 JRNL AUTH T.JU,W.BOCIK,A.MAJUMDAR,J.R.TOLMAN JRNL TITL SOLUTION STRUCTURE AND DYNAMICS OF HUMAN UBIQUITIN JRNL TITL 2 CONJUGATING ENZYME UBE2G2. JRNL REF PROTEINS V. 78 1291 2010 JRNL REFN ISSN 0887-3585 JRNL PMID 20014027 JRNL DOI 10.1002/PROT.22648 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER A. T. ET.AL. REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT BY CNS/ARIA REMARK 4 REMARK 4 2KLY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-JUL-09. REMARK 100 THE DEPOSITION ID IS D_1000101285. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 295 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 50MM NACL REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 1.0 MM [U-99% 13C; U-99% 15N] REMARK 210 HUMAN UBIQUITIN-CONJUGATING REMARK 210 ENZYME E2G2 ISOFORM 1, 90% H2O, REMARK 210 10% D2O; 0.7 MM [U-99% 15N] REMARK 210 HUMAN UBIQUITIN-CONJUGATING REMARK 210 ENZYME E2G2 ISOFORM 1, 90% H2O, REMARK 210 10% D2O; 8 MG/ML BACTERIOPHAGE REMARK 210 PF1; 1.0 MM [U-99% 13C; U-99% REMARK 210 15N] HUMAN UBIQUITIN-CONJUGATING REMARK 210 ENZYME E2G2 ISOFORM 1, 90% H2O, REMARK 210 10% D2O; 4.5% STRETCHED REMARK 210 POLYACRYLAMIDE GEL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_15N-SEPARATED_NOESY; 3D_13C REMARK 210 -SEPARATED_NOESY; 2D_NOESY; 3D REMARK 210 HNHA; IPAP-HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA; AVANCE II REMARK 210 SPECTROMETER MANUFACTURER : VARIAN; BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : 10 STRUCTURES FOR LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-10 REMARK 465 RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 HIS A 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PRO A 44 HG1 THR A 47 1.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ALA A 2 -168.80 -123.67 REMARK 500 1 ASN A 30 119.00 74.39 REMARK 500 1 GLU A 50 -94.44 -36.44 REMARK 500 1 PHE A 51 -18.47 -37.72 REMARK 500 1 LEU A 62 31.73 -76.06 REMARK 500 1 CYS A 75 46.59 -92.31 REMARK 500 1 GLU A 76 -163.91 37.84 REMARK 500 1 CYS A 89 70.34 -115.46 REMARK 500 1 MET A 101 -69.42 68.34 REMARK 500 1 PRO A 112 63.18 -62.59 REMARK 500 1 VAL A 113 -17.92 71.20 REMARK 500 1 GLN A 114 -141.46 59.86 REMARK 500 1 ASP A 132 54.22 -95.27 REMARK 500 1 SER A 134 -55.84 72.33 REMARK 500 2 PRO A 21 -97.99 -49.47 REMARK 500 2 GLU A 22 119.17 -174.32 REMARK 500 2 ASN A 30 122.25 75.53 REMARK 500 2 GLU A 31 0.25 -66.94 REMARK 500 2 PHE A 51 -14.51 75.80 REMARK 500 2 LEU A 62 37.46 -77.43 REMARK 500 2 LEU A 66 -40.80 -144.02 REMARK 500 2 ASP A 99 86.33 63.77 REMARK 500 2 GLU A 104 -166.61 -123.24 REMARK 500 2 SER A 105 -67.58 73.99 REMARK 500 2 ALA A 107 45.94 -164.65 REMARK 500 2 TRP A 110 106.59 -59.49 REMARK 500 2 PRO A 112 -5.17 -57.79 REMARK 500 2 SER A 115 128.92 50.34 REMARK 500 2 ASP A 132 75.69 -55.85 REMARK 500 2 SER A 134 -28.48 72.90 REMARK 500 2 ALA A 136 -71.10 -96.20 REMARK 500 2 ASP A 146 -78.27 -95.11 REMARK 500 3 GLU A 32 -40.69 -155.62 REMARK 500 3 PHE A 51 -19.29 83.60 REMARK 500 3 LEU A 62 35.70 -74.70 REMARK 500 3 PRO A 80 39.80 -69.28 REMARK 500 3 ASN A 81 19.98 -159.41 REMARK 500 3 HIS A 94 70.01 99.78 REMARK 500 3 ALA A 95 56.62 -165.74 REMARK 500 3 PRO A 96 -153.31 -93.31 REMARK 500 3 ASP A 98 34.81 -99.79 REMARK 500 3 ASP A 99 98.96 64.74 REMARK 500 3 MET A 101 -45.68 73.14 REMARK 500 3 GLU A 104 179.18 67.12 REMARK 500 3 SER A 105 -76.54 68.25 REMARK 500 3 ARG A 109 -65.90 -160.24 REMARK 500 3 SER A 115 134.59 44.52 REMARK 500 3 PRO A 130 108.89 -53.58 REMARK 500 3 ASN A 131 -162.99 -171.31 REMARK 500 3 ASP A 132 -16.03 82.75 REMARK 500 REMARK 500 THIS ENTRY HAS 179 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 2KLY A 1 165 UNP P60604 UB2G2_HUMAN 1 165 SEQADV 2KLY GLY A -1 UNP P60604 EXPRESSION TAG SEQADV 2KLY HIS A 0 UNP P60604 EXPRESSION TAG SEQRES 1 A 167 GLY HIS MET ALA GLY THR ALA LEU LYS ARG LEU MET ALA SEQRES 2 A 167 GLU TYR LYS GLN LEU THR LEU ASN PRO PRO GLU GLY ILE SEQRES 3 A 167 VAL ALA GLY PRO MET ASN GLU GLU ASN PHE PHE GLU TRP SEQRES 4 A 167 GLU ALA LEU ILE MET GLY PRO GLU ASP THR CYS PHE GLU SEQRES 5 A 167 PHE GLY VAL PHE PRO ALA ILE LEU SER PHE PRO LEU ASP SEQRES 6 A 167 TYR PRO LEU SER PRO PRO LYS MET ARG PHE THR CYS GLU SEQRES 7 A 167 MET PHE HIS PRO ASN ILE TYR PRO ASP GLY ARG VAL CYS SEQRES 8 A 167 ILE SER ILE LEU HIS ALA PRO GLY ASP ASP PRO MET GLY SEQRES 9 A 167 TYR GLU SER SER ALA GLU ARG TRP SER PRO VAL GLN SER SEQRES 10 A 167 VAL GLU LYS ILE LEU LEU SER VAL VAL SER MET LEU ALA SEQRES 11 A 167 GLU PRO ASN ASP GLU SER GLY ALA ASN VAL ASP ALA SER SEQRES 12 A 167 LYS MET TRP ARG ASP ASP ARG GLU GLN PHE TYR LYS ILE SEQRES 13 A 167 ALA LYS GLN ILE VAL GLN LYS SER LEU GLY LEU HELIX 1 1 GLY A 3 ASN A 19 1 17 HELIX 2 2 SER A 115 GLU A 129 1 15 HELIX 3 3 ASN A 137 ASP A 146 1 10 HELIX 4 4 ASP A 147 GLY A 164 1 18 SHEET 1 A 4 ILE A 24 PRO A 28 0 SHEET 2 A 4 GLU A 36 MET A 42 -1 O GLU A 38 N GLY A 27 SHEET 3 A 4 VAL A 53 SER A 59 -1 O ALA A 56 N ALA A 39 SHEET 4 A 4 LYS A 70 PHE A 73 -1 O LYS A 70 N SER A 59 CISPEP 1 TYR A 64 PRO A 65 1 0.96 CISPEP 2 TYR A 64 PRO A 65 2 -0.66 CISPEP 3 TYR A 64 PRO A 65 3 0.40 CISPEP 4 TYR A 64 PRO A 65 4 6.82 CISPEP 5 TYR A 64 PRO A 65 5 0.35 CISPEP 6 TYR A 64 PRO A 65 6 2.07 CISPEP 7 TYR A 64 PRO A 65 7 -1.96 CISPEP 8 TYR A 64 PRO A 65 8 -8.58 CISPEP 9 TYR A 64 PRO A 65 9 3.40 CISPEP 10 TYR A 64 PRO A 65 10 0.41 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000